Today: 2 February 2026
Subscribe
Browse Category

IPO News News 17 December 2025 - 22 December 2025

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

December 22, 2025 — Barrick Mining Corporation stock is ending the year with a rare triple tailwind: a fresh record in gold prices, a major geopolitical overhang easing in Mali, and an ongoing strategic shake-up that could materially change how the market values the company’s North American assets. Gold pushed through $4,400 per ounce for the first time on Monday,…
22 December 2025
·····
Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Limited’s newly listed stock is doing what freshly public, hotly debated consumer-tech names often do: sprint, stumble, then dare investors to tell a coherent story about what “fair value” even means. On Monday, December 22, 2025, Meesho shares were trading around ₹209–₹212 by midday, down roughly 6–7% versus the prior close, after an eye-catching post-IPO surge that briefly pushed…
22 December 2025
····
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

Mumbai/Bengaluru — December 21, 2025 — The National Stock Exchange of India (NSE) is ending 2025 in a situation that would have sounded contradictory a few years ago: India is home to one of the biggest derivatives machines on Earth, yet the country’s flagship equity market is behaving like it’s on sedatives. Options traders are being forced to rethink playbooks,…
21 December 2025
··
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease acquisition, a closely watched FDA approval in cardiology, IPO paperwork from both biotech and medtech, and a sweeping wave of…
21 December 2025
······
Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

The Shanghai Stock Exchange (SSE) heads into the final full trading stretch of 2025 with two stories unfolding at once: a steadier, policy-sensitive main board and a turbo-charged STAR Market where “hard tech” listings—especially AI chipmakers—are setting the tone for risk appetite. As of Sunday, Dec. 21 (when the mainland market is closed), the latest official close for the benchmark…
21 December 2025
·
Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Ltd (NSE: RELIANCE; BSE: 500325) heads into the final stretch of 2025 with its stock trading close to a fresh 52-week peak—powered by a familiar Reliance cocktail: strong refining economics, rising confidence in consumer-facing cash flows, and a growing “value-unlocking” narrative around Jio. LiveMint RIL shares closed Friday, December 19, at ₹1,565.10, leaving the stock roughly 1% below…
21 December 2025
······
Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

NEW YORK, Dec. 19, 2025 — Morgan Stanley stock (NYSE: MS) traded higher Friday as investors weighed a cluster of catalysts: a Reuters report that the bank is emerging as a leading candidate to help run a potential SpaceX initial public offering, a drumbeat of upbeat industry outlooks for 2026 dealmaking, and a growing focus on Morgan Stanley’s upcoming fourth-quarter…
19 December 2025
·····
Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

December 19, 2025 — Navan, Inc. (NASDAQ: NAVN) stock is sharply higher in Friday trading, putting the newly public corporate travel-and-expense platform back on traders’ screens just days after its debut earnings report triggered a steep selloff. The immediate catalyst: a notable open-market insider purchase disclosed in an SEC filing, which helped shift the day’s narrative from “post‑earnings pain” to…
19 December 2025
·····
Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. (Nasdaq: MDLN) is getting a quick reality check after one of the biggest U.S. IPO debuts in years. After the closing bell on Thursday, December 18, 2025, Medline stock finished the regular session at $39.98 (down 2.49% on the day) and traded around $39.49 in after-hours action, after moving between $38.00 and $41.74 during the day. Investing The…
18 December 2025
·····
Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Updated: December 18, 2025 — Gujarat Kidney and Super Speciality Ltd has finalised the price band for its upcoming mainboard IPO, setting the stage for a ₹251 crore public issue that will open next week. The offer is entirely a fresh issue—meaning the company (not selling shareholders) will receive the proceeds—at a time when investors are tracking healthcare listings closely…
18 December 2025
···
Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Updated: 4:40 PM ET (Dec. 17, 2025) The Nasdaq Stock Market closed sharply lower on Wednesday as renewed anxiety around the “AI trade” hit megacap technology and chip leaders, sending the Nasdaq Composite down 418.14 points (-1.81%) to 22,693.32—a three-week low—despite a headline-grabbing IPO debut on the exchange and a late-day after-hours surge in Micron following blockbuster guidance.  Reuters Below is…
17 December 2025
·······
Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (LSE: PRU) confirmed the underwriting agreement and final prospectus filing for the ICICI Prudential Asset Management IPO, while continuing share repurchases and trading near a new 52‑week high. Prudential plc (LSE: PRU; HKEX: 2378) delivered a busy set of updates on Wednesday, 17 December 2025, putting its India-linked asset management monetisation and shareholder capital returns back in the…
17 December 2025
·····
1 2 3 4 5 6 … 10

Stock Market Today

  • Klaviyo (KVYO) Share Price Drops 52% Amid Mixed Valuation Signals
    February 2, 2026, 8:08 AM EST. Klaviyo's shares have plummeted 52.4% over the past year, closing recently at $22.21. The marketing automation company's fall has sparked debate on whether the stock now offers a bargain or remains overpriced. A Discounted Cash Flow (DCF) analysis values Klaviyo at $11.70 per share, suggesting an 89.8% overvaluation relative to the current price. Despite free cash flow projections increasing through 2035, the DCF model's conservative estimates weigh heavily. Klaviyo trades at a price-to-sales (P/S) ratio of 5.81, reflecting investor expectations for growth amid concerns about execution risks. The stock's mixed valuation signals fuel ongoing uncertainty about its long-term prospects within the software sector.
Go toTop